We are excited to share that encevis has been featured in a recent comparative study on commercial seizure detection software, published in Clinical Neurophysiology. The study reports that encevis 2.0 achieved a mean seizure detection rate per patient of up to 89.1%, with false positive rates as low as 0.5 per hour in a large dataset.

These findings highlight our ongoing commitment to developing reliable EEG analysis solutions that support clinicians in their diagnostic processes.

Read the full study here: https://www.sciencedirect.com/science/article/pii/S1388245725005632